Monoclonal antibody COVID treatment induces drug-resistant SARS-CoV-2 mutants
Our Approach
Our Pipeline
Investors
Team
Key Publications
Collaboration or Partnering
News
Contact
Monoclonal antibody COVID treatment induces drug-resistant SARS-CoV-2 mutants